ArticleTranslational lung cancer research2025

Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer.

Kaitlyn M Tsuruda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.